BioIntelliSense makes remote patient monitoring possible with its BioButton wearable, which continuously tracks vital signs to support at-home care. The device is designed to be comfortable and discreet, and it sends data to analytics that help clinicians spot early signs of health issues for proactive intervention. It primarily serves hospitals, health systems, provider organizations, and payors in the U.S. and select global markets, selling wearables and providing data analytics services. Its approach centers on cost-effectiveness, ease of use, and healthcare partnerships to improve patient outcomes while reducing costs from hospital stays and emergency care.
Company Size
51-200
Company Stage
Series B
Total Funding
$82M
Headquarters
Golden, Colorado
Founded
2018
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?